Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ijcard.2015.09.055 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Case report: Unveiling the silent threat in the ICU - a case of disseminated invasive aspergillosis in a patient with fulminant myocarditis.
Front Immunol
December 2024
Fourth Department of Critical Care Medicine, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou, Fujian, China.
Invasive aspergillosis (IA) significantly increases mortality in critically ill patients in the ICU and its occurrence is closely related to immunocompromise. Dissemination of IA is easily misdiagnosed and mistreated due to its ability to invade multiple systems throughout the body and lack of typical clinical manifestations. In this case, a 25-year-old previously healthy woman was hospitalized with fulminant myocarditis and treated with veno-arterial extracorporeal membrane pulmonary oxygenation (VA-ECMO) support and intravenous acyclovir, high-dose methylprednisolone, and immunoglobulin.
View Article and Find Full Text PDFRe-emergence of Bagaza virus in wild birds from southern Spain.
Vet Microbiol
November 2024
Departamento de Sanidad Animal, Grupo de Investigación en Sanidad Animal y Zoonosis (GISAZ), UIC Zoonosis y Enfermedades Emergentes ENZOEM, Universidad de Córdoba, 14014 Córdoba , Spain; CIBERINFEC, ISCIII - CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, 28029 Madrid, Spain.
Bagaza virus (BAGV; Orthoflavivirus bagazaense) is an emerging vector-borne flavivirus affecting avian species with severe implications for animal health, and whose zoonotic potential has also been suggested. The aim of the present study was to monitor the epidemic outbreak of BAGV in wild birds from Spain in 2021. BAGV cases were confirmed in game bird species, including red-legged partridges (Alectoris rufa) and common pheasants (Phasianus colchicus) from 24 hunting areas.
View Article and Find Full Text PDFMyocarditis - A silent killer in athletes: Comparative analysis on the evidence before and after COVID-19 pandemic.
Sports Med Health Sci
September 2024
Pauley Heart Center, Division of Cardiology, Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA, 23298-0204, USA.
Article Synopsis
- Myocarditis is a rare type of heart inflammation often caused by viruses, and it poses serious health risks for both athletes and the general population, especially after COVID-19.
- Research indicates that COVID-19, caused by the SARS-CoV-2 virus, increases the risk of myocarditis, but athletes seem to have a lower risk than everyone else.
- The study emphasizes the need for better monitoring and management of myocarditis in athletes, particularly given their unique risk factors and the potential for life-threatening complications like sudden cardiac death, to improve return-to-play guidelines post-COVID-19.
Cardiac Sarcoidosis: A Comprehensive Clinical Review.
Rev Cardiovasc Med
February 2024
Division of Non-Invasive Cardiology, Department of Medicine, University of Szeged, 6720 Szeged, Hungary.
Sarcoidosis is an inflammatory multisystemic disease of unknown etiology characterized by the formation of non-caseating granulomas. Sarcoidosis can affect any organ, predominantly the lungs, lymphatic system, skin and eyes. While 90% of patients with sarcoidosis have lung involvement, an estimated 5% of patients with sarcoidosis have clinically manifest cardiac sarcoidosis (CS), whereas approximately 25% have asymptomatic, clinically silent cardiac involvement verified by autopsy or imaging studies.
View Article and Find Full Text PDFUnrecognized myocardial scar by late-gadolinium-enhancement cardiovascular magnetic resonance: Insights from the population-based Hamburg City Health Study.
J Cardiovasc Magn Reson
June 2024
Department of Cardiology, University Heart and Vascular Center Hamburg Eppendorf, Hamburg, Germany; Deutsches Zentrum für Herz-Kreislauf-Forschung e.V. (German Center for Cardiovascular Research), Partner Site Hamburg/Kiel/Lübeck, Germany, Hamburg, Germany.
Article Synopsis
- A population study of 1,064 participants found that 23% had unrecognized myocardial scar (UMS), indicating a significant prevalence of this condition in people without known heart disease.
- UMS was mostly non-ischemic (89%), often affecting the basal inferolateral left ventricle, and was linked to lower left ventricular ejection fraction (LVEF) and higher LV mass.
- Specifically, ischemic UMS was associated with lower LVEF, higher LV mass, and a history of diabetes, highlighting the importance of assessing UMS for better understanding cardiac health.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!